The Infratil Ltd (ASX: IFT) share price is on the rise today after the company announced it plans to acquire up to 60% of Qscan Group Holdings Pty Ltd from Quadrant Private Equity. At the time of writing, the Infratil share price is up 2.66% to $5.40 after reaching as high as $5.55 in morning trade. The potential deal is for a total cash equity consideration of up to $330 million. Qscan is a comprehensive diagnostic imaging practice with locations throughout Australia. The Infratril share price is responding positively to an implied enterprise value (EV) to earnings before interest, taxes, depreciation and amortisation (EBITDA) of 12.7-14.1.
What’s moving the Infratril share price?
In June 2020, Infratil raised additional equity of NZ$300 million to pursue its growth agenda and take advantage of investment opportunities that may arise. This capital paid down bank facilities and, consequently, can be used to fund the Qscan acquisition, news of which is driving the Infratril share price higher today. Infratil has made the offer in conjunction with the Morrison & Co Growth Infrastructure Fund (MGIF), which has conditionally offered to acquire up to ~15% of Qscan.
Qscan grew from initially operating a single clinic and hospital contract. Today, it is a group operating a portfolio of 70+ clinics across Australia. This includes a network of 10 clinics offering Positron Emission Tomography (PET) in oncology.
The acquisition, if successful, will provide Infratril with a foothold in the very lucrative healthcare diagnostics and imaging sector. At present, the company has invested in defensive shares, such as Tilt Renewables Ltd (ASX: TLT).
The Qscan investment will be managed by Morrison & Co on behalf of Infratril and MGIF. Moreover, it is conditional on doctor and management shareholders holding the equivalent of ~25% to 32.5% of the business post-close. This therefore requires reinvestment of some of the proceeds into the new holding vehicle. Furthermore, investors in the Infratril share price appear happy with the shared risk, and the diversification into medical imaging.
Marko Bogoievski, CEO of Infratil said of the acquisition:
Qscan provides a high-quality entry point into a sector with structural long-term growth and potential to scale into a leading healthcare infrastructure platform…
The Diagnostic Imaging sector benefits from long-term demographic tailwinds and technological advances that will allow it to play a growing role in the early detection of diseases such as cancer. Ultimately, increased investment in Diagnostic Imaging will reduce overall healthcare system costs while improving patient outcomes.
Paul Newfield, head of Australia and New Zealand for Morrison & Co, commented:
Qscan is a market leader in a growth industry. It has a secure revenue base backed by strong referral networks. In addition, there is a track record of strong, profitable growth, with significant further growth potential, Qscan is also known for the quality of its Doctors and the strength of their sub-specialty expertise.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Will the Liberty IPO damage the Commonwealth Bank (ASX:CBA) share price? – November 23, 2020 4:02pm
- Why the Fortescue (ASX:FMG) share price is shooting up more than 5% today – November 23, 2020 12:37pm
- ASX 200 events this week that could move the market – November 23, 2020 11:53am